Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf
Clinical trial NCT05266469 · COMPLETED
Trial details
- NCT number
- NCT05266469
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-26
- Primary completion
- 2024-11-11
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.